(Q33542907)

27 July 2017

1 reference

title

Pain in the rheumatic diseases. Practical aspects of diagnosis and treatment (English)

1 reference

27 July 2017

Rice JR

1

1 reference

PubMed ID

10083957

27 July 2017

Pisetsky DS

series ordinal

2

1 reference

27 July 2017

1 February 1999

1 reference

Rheumatic Diseases Clinics of North America

27 July 2017

1 reference

27 July 2017

25

1 reference

27 July 2017

1

1 reference

27 July 2017

15-30

1 reference

Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

The concurrence of lupus and fibromyalgia: implications for diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Fibromyalgia syndrome and myofascial pain syndrome. Do they exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Coping with arthritis pain. A review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

A clue from a self-report questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. The P-VAS:D-ADL ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Chronic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

More pain, more tender points: is fibromyalgia just one end of a continuous spectrum?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Selection of analgesic therapies in rheumatoid arthritis: the role of opioid medications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Differing correlations between pain measures in syndromes with or without explicable organic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

The neuroscience and endocrinology of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Range of antinuclear antibodies in "healthy" individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Fibromyalgia: what's next?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

The prevalence and characteristics of fibromyalgia in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970053-3

7 January 2021

10.1016/S0889-857X(05)70053-3

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

10083957